Genomic sequence of the RA27/3 vaccine strain of rubella virus

• Published in: Archives of virology 1997-01, Vol.142 (6), p.1165-1180
• Main Authors: PUGACHEV, K. V, ABERNATHY, E. S, FREY, T. K
• Format: Article
• Language: English
• Subjects: Amino Acid Sequence; Animals; Base Sequence; Biological and medical sciences; Cercopithecus aethiops; DNA, Viral; Fundamental and applied biological sciences. Psychology; Genome, Viral; Microbiology; Molecular Sequence Data; Rubella Vaccine - genetics; Rubella virus; Rubella virus - genetics; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies; Vero Cells; Virology
• ISSN: 0304-8608; 1432-8798
• DOI: 10.1007/s007050050150

The sequence of the genome of the RA27/3 vaccine strain of rubella virus (RUB) was determined. In the process, several discrepancies between the previously reported genomic sequences of two wild RUB strains (Therien and M33) were resolved. The genomes of all three strains contain 9762 nucleotides (nts), exclusive of the 3' poly A tract. In all three strains, the genome contains (5' to 3'), a 40 nt 5' untranslated region (UTR), an open reading frame (ORF) of 6348 nts that encodes nonstructural proteins, a 123 nt UTR between the two genomic ORFs, a 3189 nt ORF that encodes the structural proteins, and a 62 nt 3' UTR. The 5' end of the subgenomic RNA was found to correspond to a uridine residue at nt 6436 of the genomic RNA. At the nucleotide level, the sequence of the three strains varied by 1.0 to 2.8%, while at the amino acid level, the sequence varied by 1.1 to 2.4% over both ORFs. The RA27/3 sequence will be of use in identification of the determinants of its attenuation, in vaccine production control and in development of second generation RUB vaccines based on recombinant DNA technology.